International

Monkeypox vaccine ‘IMVANEX’ approved in Europe

Published on 27 Jul 2022

← Back to Current Affairs
  • The European Commission has approved a smallpox vaccine for use against monkeypox after the World Health Organization declared monkeypox a global health emergency.
  • Imvanex has been approved in the EU since 2013 for the prevention of smallpox.
  • It was also considered a potential vaccine for monkeypox because of the similarity between the monkeypox virus and the smallpox virus.
  • Monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980.
  • The first symptoms of monkeypox are fever, headaches, muscle pain and back pain during the course of five days.

Discussion 0

No comments yet. Be the first to share your thoughts!

Join WhatsApp